1. Home
  2. TARS vs OFG Comparison

TARS vs OFG Comparison

Compare TARS & OFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TARS
  • OFG
  • Stock Information
  • Founded
  • TARS 2016
  • OFG 1964
  • Country
  • TARS United States
  • OFG United States
  • Employees
  • TARS N/A
  • OFG N/A
  • Industry
  • TARS Medicinal Chemicals and Botanical Products
  • OFG Major Banks
  • Sector
  • TARS Health Care
  • OFG Finance
  • Exchange
  • TARS Nasdaq
  • OFG Nasdaq
  • Market Cap
  • TARS 1.7B
  • OFG 1.9B
  • IPO Year
  • TARS 2020
  • OFG N/A
  • Fundamental
  • Price
  • TARS $41.17
  • OFG $44.27
  • Analyst Decision
  • TARS Strong Buy
  • OFG Buy
  • Analyst Count
  • TARS 7
  • OFG 3
  • Target Price
  • TARS $67.14
  • OFG $44.00
  • AVG Volume (30 Days)
  • TARS 594.1K
  • OFG 266.8K
  • Earning Date
  • TARS 08-07-2025
  • OFG 07-17-2025
  • Dividend Yield
  • TARS N/A
  • OFG 2.68%
  • EPS Growth
  • TARS N/A
  • OFG 6.67
  • EPS
  • TARS N/A
  • OFG 4.18
  • Revenue
  • TARS $233,674,000.00
  • OFG $623,009,000.00
  • Revenue This Year
  • TARS $122.94
  • OFG $2.30
  • Revenue Next Year
  • TARS $44.14
  • OFG $2.61
  • P/E Ratio
  • TARS N/A
  • OFG $10.70
  • Revenue Growth
  • TARS 449.03
  • OFG N/A
  • 52 Week Low
  • TARS $20.08
  • OFG $33.15
  • 52 Week High
  • TARS $57.28
  • OFG $47.66
  • Technical
  • Relative Strength Index (RSI)
  • TARS 43.15
  • OFG 69.60
  • Support Level
  • TARS $38.52
  • OFG $44.34
  • Resistance Level
  • TARS $41.48
  • OFG $45.32
  • Average True Range (ATR)
  • TARS 1.51
  • OFG 0.80
  • MACD
  • TARS 0.12
  • OFG 0.24
  • Stochastic Oscillator
  • TARS 48.21
  • OFG 91.83

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

About OFG OFG Bancorp

OFG Bancorp is a financial holding company, through its subsidiaries provides banking and financial services. It operates through three segments namely Banking, Wealth Management, and Treasury. It serves to clients such as commercial, consumer, auto, and mortgage lending, checking and savings accounts, financial planning, insurance, financial services, and investment brokerage, and corporate and individual trust and retirement services. The company derives maximum revenue from Banking Segment. It provides services in the region of Puerto Rico.

Share on Social Networks: